BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 620910)

  • 1. Bioavailability of cimetidine in man.
    Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
    Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cimetidine pharmacokinetics].
    Katrukha SP; Karpenko EV; Davydov SM; Blinkov IL; Kukes VG
    Farmakol Toksikol; 1986; 49(5):36-40. PubMed ID: 3770173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of cimetidine in pediatric duodenal ulcer.
    Kato S; Watanabe N; Harada Y
    Clin Ther; 1991; 13(1):118-25. PubMed ID: 2029717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetics of cimetidine.
    Grahnén A; von Bahr C; Lindström B; Rosén A
    Eur J Clin Pharmacol; 1979 Nov; 16(5):335-40. PubMed ID: 520401
    [No Abstract]   [Full Text] [Related]  

  • 8. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
    Rogers HJ; Morrison P; House FR; Bradbrook ID
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.
    Citron ML; Reynolds JR; Kalra J; Kay BG; Nathan KA; Jaffe ND; Miller FR
    Cancer Treat Rep; 1987 Mar; 71(3):317-9. PubMed ID: 3815397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine bioavailability after massive small bowel resection.
    Russo J; Watson WA; Nelson EW; Schentag JJ
    Clin Pharm; 1982; 1(6):558-61. PubMed ID: 7185547
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of cimetidine following administration of a single dose by the rapid intravenous route and by the oral route].
    Arancibia A; Schindler I; Paccot E; Ruiz I; Gonzalez G; Mella F; Thambo S
    Therapie; 1985; 40(2):87-92. PubMed ID: 4002195
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability study of two tablet formulations of cimetidine.
    Berardi RR; Cohen IA; Hyneck ML; Lockwood GF; Shukla UA; Sakmar E; Wells JJ; Wagner JG
    Biopharm Drug Dispos; 1984; 5(2):169-76. PubMed ID: 6743784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.